Amgen To Webcast Investor Call At ASH 2018

THOUSAND OAKS, Calif., Nov. 28, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for the investment community at the 60th American Society of Hematology (ASH) Annual Meeting & Exposition on Monday, Dec. 3, 2018, at 8 p.m. PT. David M. Reese, M.D., executive vice president of Research and Development at Amgen, together with other members of Amgen's management team and a clinical investigator, will participate to discuss data presented at ASH and the Company's oncology program, including the bispecific T Cell engager (BiTE®) immuno-oncology platform. Live audio of the investor call will be simultaneously broadcast over the Internet and will be available to members of the...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news